These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34932603)

  • 21. Longer survival associated with HLA-A*03, B*14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping.
    Barton JC; Barton JC; Acton RT
    Eur J Haematol; 2010 Nov; 85(5):439-47. PubMed ID: 20722701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
    Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
    Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers.
    Deugnier Y; Morcet J; Lainé F; Hamdi-Roze H; Bollard AS; Guyader D; Moirand R; Bardou-Jacquet E
    J Hepatol; 2019 Jan; 70(1):118-125. PubMed ID: 30244162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
    Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC;
    J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron overload and cirrhosis in referred
    Adams PC; Barton JC
    Can Liver J; 2020; 3(2):188-193. PubMed ID: 35991852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary Hemochromatosis Associations with Frailty, Sarcopenia and Chronic Pain: Evidence from 200,975 Older UK Biobank Participants.
    Tamosauskaite J; Atkins JL; Pilling LC; Kuo CL; Kuchel GA; Ferrucci L; Melzer D
    J Gerontol A Biol Sci Med Sci; 2019 Feb; 74(3):337-342. PubMed ID: 30657865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
    World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemochromatosis and alcoholic liver disease.
    Fletcher LM; Powell LW
    Alcohol; 2003 Jun; 30(2):131-6. PubMed ID: 12957297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Penetrance of Hereditary Hemochromatosis-Related End-Organ Damage of C282Y Homozygosity, A Newfoundland Experience.
    Lim DR; Vidyasankar G; Phua C; Borgaonkar M
    Clin Transl Gastroenterol; 2020 Nov; 11(11):e00258. PubMed ID: 33259166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
    Pelucchi S; Mariani R; Calza S; Fracanzani AL; Modignani GL; Bertola F; Busti F; Trombini P; Fraquelli M; Forni GL; Girelli D; Fargion S; Specchia C; Piperno A
    Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
    Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content.
    Barton JC; Bertoli LF; Rothenberg BE
    J Lab Clin Med; 2000 Jan; 135(1):96-104. PubMed ID: 10638700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HFE genotype in patients with hemochromatosis and other liver diseases.
    Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
    Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE.
    Bardou-Jacquet E; Morandeau E; Anderson GJ; Ramm GA; Ramm LE; Morcet J; Bouzille G; Dixon J; Clouston AD; Lainé F; Turlin B; Powell LW; Deugnier YM
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1851-1857. PubMed ID: 31622736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.